The UCA1 upregulation has been directly and significantly associated with certain clinicopathological characteristics of GBC patients including tumor size, lymph node metastasis, TNM stage, and poor overall survival time compared to patients with lower levels of UCA1 [12]. This evidence concerns the gene UCA1 and metastasis.